Search

You searched for "funding"

2820 results found

Introducing Danny Laycock, talent solutions specialist for the ophthalmology sector with a truly global reach

6 July 2023 | Recruitment & Personnel
Is your company changing the future of Ophthalmics? We’re collating a list of the top companies to watch in the space for 2024.

The Worshipful Company of Spectacle Makers awards two Master’s Medals for early career research

21 October 2025 | WCSM, early career, awards, genetics, AI
The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of two Master’s Medals for 2025. Fabian Yii from Edinburgh was awarded the Master’s Medal for his paper, 'Fundus Refraction Offset as a Personalized Biomarker for 12-Year Risk...

SCOPE Independent Prescriber Bursary 2024 Awards

18 July 2024 | optometry, optometrist, bursary, opportunities, funding, money, opticians, awards, competition
SCOPE celebrates excellence in optometry with the 2024 Independent Prescriber Bursary Awards.

It’s easy when you know the rules

1 June 2019 | | EYE - Vitreo-Retinal, EYE - General
As I was travelling along a deserted road on a Sunday last month I saw in my peripheral vision a disconcerting flash of light behind me. Much as I tried to convince myself that the flash was due to the...

Registration launches for 100% Optical and 100% Ophthalmology 2026

4 September 2025 | events, meetings, preview, UK
Organisers have announced that free registration for 100% Optical, the UK’s largest optical exhibition, and its co-located event, 100% Ophthalmology, will be live in the first week of September. Where eyecare meets eyewear, the award-winning event for the Optical and...

Radiation retinopathy

5 June 2020 | | EYE - Vitreo-Retinal, EYE - General
The authors review the current treatment options for this condition. Radiation retinopathy (RR) occurs as a complication after exposure to any type of radiation (external beam, plaque brachytherapy and stereotactic radiosurgery) in the orbital or adnexal region. These include nasopharyngeal...

“Beware of the pigment”

4 August 2021 | | EYE - Glaucoma, EYE - General
Using some captivating artwork, Iheukwumere Duru describes key features of pigment dispersion syndrome. Pigmentary dispersion syndrome (PDS) leads to pigmentary glaucoma (PG) in approximately 35-50% of patients with the condition [1]. PG is the leading cause of non-traumatic blindness in...

NHS staffing experts back insourcing as practical solution to long NHS waiting lists

30 October 2023 | insourcing, outsourcing, NHS, waiting list, Claire Dubowski, 18 Week Support
NHS staffing experts back insourcing as practical solution to long NHS waiting lists amid cross-party consensus on the need for increased independent sector support.

Apr/May 2015 Quiz

1 April 2015 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
History A 60-year-old man presented to the ophthalmologists with painful blurred left vision. Examination revealed a white vascular mass, occupying 60% of the anterior chamber space, arising from the iris. After conservative therapy, no useful vision remained. The eye was...

A trainee’s guide on how to prepare for the digital age of ophthalmology

6 April 2021 | | EYE - General
As the pandemic rolls on, the past year has left many ophthalmic departments in disarray with ever-lengthening patient waiting-lists and increasing challenges in service delivery. Areas such as virtual clinics, telephone / video consultations have had to mature rapidly to...

Treatment for cause of sudden sight loss now available through the NHS in England

24 September 2025 | LHON, NICE, vision Loss, mitochondrial disease, NHS England
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

NICE approves treatment for cause of sudden sight loss

15 October 2025 | genetics, neuro-ophthalmology, drugs, new treatments, mitochondrial
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...